Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples

Proceedings of the Society for Experimental Biology and Medicine

Volumn 222, Issue 2, 1999, Pages 178-184

  Diwadkar, Veda A ^a   Anderson, James W ^a,b   Bridges, Susan R ^a   Gowri, Maya S ^a   Oelgten, Peter R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Medical Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032747655     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-129.x     Document Type: Article

References (36)

1. Joslin EP. Arteriosclerosis and diabetes. Ann Clin Med 5:1061, 1927.
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. Br Med J 287:867-870, 1983.
3. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogenesis. Diabetes Care 14:839-855, 1991.
4. Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in noninsulin-dependent diabetes mellitus. Annals Med 28:341-345, 1996.
5. Taskinen M, Lahdenpera S, Syvanne M. New insights into lipid metabolism in noninsulin-dependent diabetes mellitus. Ann Med 28:335-340, 1996.
6. Lyons TJ. Oxidized low-density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes? Diabet Med 8:411-419, 1991.
7. Steinberg D, Parthasarthy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low-density lipoproteins that increase in atherogenicity. N Engl J Med 320:915-923, 1989.
8. Witztum JL. Role of oxidized low-density lipoprotein in atherogenesis. Br Heart J 69:S12-S18, 1993.
9. Young SG, Parthasarthy S. Why are low-density lipoproteins atherogenic? West J Med 160:153-164, 1994.
10. Jialal I, Devaraj S. The role of oxidized low-density lipoprotein in atherogenesis. J Nutr 126:10535-10575, 1996.
11. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The yin and yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff Memorial lecture. Arterioscler Thromb Vasc Biol 16:831-842, 1996.
12. Esterbauer H, Ramos P. Chemistry and pathophysiology of oxidation of LDL. Rev Physiol Biochem Pharmacol 127:31-64, 1995.
13. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 60:473-485, 1979.
14. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29:469-179, 1988.
15. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Kay Dunn J, Gotto AM Jr., Patsch W. Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb Vasc Biol 12:1336-1345, 1992.
16. Lechleitner M, Hoppichler F, Foger B, Patsch JR. Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb Vasc Biol 14:1799-1807, 1994.
17. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and atherosclerosis in man. Lancet 339:1183-1186, 1992.
18. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation. Clin Chem 18:499-502, 1972.
19. Chung BH, Wilkinson T, Greer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: Rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 21:284-292, 1980.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
21. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res 6:67-75, 1988.
22. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627-630, 1989.
23. Kosugi H, Kikugawa K. Thiobarbituric acid reaction of aldehydes and oxidized lipids in glacial acetic acid. Lipids 20:915, 1985.
24. Steinbrecher UP. Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. Biol Chem 262:3603-3608, 1987.
25. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 9:693-700, 1968.
26. Beaudeux J, Guillausseau P, Peynet J, Flourie F, Assayag M, Tielmans D, Warnet A, Rousselet F. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in Type 1 and Type 2 diabetic patients. Clin Chim Acta 239:131-141, 1995.
27. Anderson JW, Gowri MS, Turner J, Nichols L, Diwadkar VA, Chow CK, Oeltgen PR. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with Type 2 diabetes mellitus. J Am Coll Nutr 18 (in press).
28. Lahdenpera S, Syvanne M, Kahri J, Taskinen MR. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: Importance of serum triglycerides. Diabetologia 39:453-461, 1996.
29. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low- and high-density lipoproteins. Arteriosclerosis 4:225-231, 1984.
30. Dachet C, Motta C, Neufcour D, Jacotot B. Fluidity changes and chemical composition of lipoproteins in Type IIa hyperlipoproteinemia. Biochim Biophys Acta 1046:64-72, 1990.
31. Mosinger B. Copper-induced and photosensitive oxidation of serum low-density lipoprotein: The relation to cholesterol level and interspecies differences. Biochim Biophys Acta 1270:73-80, 1995.
32. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. Circulation 82:495-506, 1990.
33. McNamara JR, Jenner JL, Liu Z, Wilson PWF, Schaefer FJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb Vasc Biol 12:1284-1290, 1992.
34. Griffin BA, Freeman DJ, Tait G, Thompson J, Caslake MJ, Packhard CJ, Shepherd J. Role of plasma triglycerides in the regulation of plasma low-density lipoprotein (LDL) subfractions: Relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253, 1994.
35. Lewis GF, O'Meara MM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72:934-944, 1991.
36. Dejager S, Bruchert E, Chapman MJ. Dense low-density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 34:295-308, 1993.